Concepedia
Statistics
Publications
27
Citations
2.2K
H-Index
20
Active since
1977
Affiliations
New Frontier(Current)
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (United States)
Molecular Discovery (United Kingdom)
The University of Texas Medical Branch at Galveston
Ron Boon is an author at New Frontier specializing in medicine, health sciences, and antibiotics.
Top concepts
MedicineHealthAntibioticsMicrobiologyPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug ResistanceInfection ControlPharmacotherapy
Publications per year
1977–2003
Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial
Stephen K. Tyring, Rick A. Barbarash, James E. Nahlik et al. · Annals of Internal Medicine · 1995 · 495 citations
Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use
R. Sutherland, Ron Boon, Karen E. Griffin et al. · Antimicrobial Agents and Chemotherapy · 1985 · 334 citations · Full text
Antibacterial Activity, Antimicrobial Chemotherapy, Antibiotic Resistance +18
Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spotswood L. Spruance, Ted Rea, Christopher Thoming et al. · PubMed · 1997 · 181 citations
Famciclovir for the Suppression of Symptomatic and Asymptomatic Herpes Simplex Virus Reactivation in HIV-Infected Persons: A Double-Blind, Placebo-Controlled Trial
Timothy W. Schacker, Hui Hu, David M. Koelle et al. · Annals of Internal Medicine · 1998 · 177 citations
Postherpetic Neuralgia: Impact of Famciclovir, Age, Rash Severity, and Acute Pain in Herpes Zoster Patients
Robert H. Dworkin, Ron Boon, David R. G. Griffin et al. · The Journal of Infectious Diseases · 1998 · 127 citations · Full text
Pain Therapy, Acute Pain, Rash Severity +19
1–5 of 27